{"id":908475,"date":"2025-11-11T09:53:03","date_gmt":"2025-11-11T14:53:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/"},"modified":"2025-11-11T09:53:03","modified_gmt":"2025-11-11T14:53:03","slug":"myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/","title":{"rendered":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SALT LAKE CITY, Nov.  11, 2025  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=OBihZgcPoJstIc0IwpcIjZ6tlAbD_nZOFhVMOFzIGUK4ybJnSH5k9PzYsT0g1CER2nPjq3Slz9iKOlTFTW3105uLZCjPZLBe_JZ_i48lQyo=\" rel=\"nofollow\" target=\"_blank\">Myriad Genetics, Inc<\/a>. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences.<\/p>\n<ul type=\"disc\">\n<li>The 7<sup>th<\/sup> Annual Wolfe Research Healthcare Conference with a fireside chat on Tuesday, Nov. 18, 2025, at 1:20 pm ET.\n<\/li>\n<li>The 37<sup>th<\/sup> Annual Piper Sandler Healthcare Conference with a fireside chat on Tuesday, Dec. 2, 2025, at 12:00 pm ET.<\/li>\n<\/ul>\n<p>The presentations will be available through live audio webcast links in the investor information section of Myriad\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=UoPfCNgO787oJxhCYBf-IYEhrtZDY_b1hsZf1HZ4PVVCxIibTucCf5pRaL1kYMS0Ma2vtJFkybiwalCPN4MlD_udTFI344HetS0wv1feFxI=\" rel=\"nofollow\" target=\"_blank\">investor.myriad.com<\/a>.\u00a0<\/p>\n<p>\n        <strong>About Myriad Genetics<\/strong><br \/>\n        <br \/>Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oqPC_zP3TGb3b6t7tO5BibKWnS-2MQwx5r3CIqf0NCqpETV1Yuo0IBinFXGDNbieQRLct5z70UWGIA7gAFRtXw==\" rel=\"nofollow\" target=\"_blank\">www.myriad.com<\/a>.<\/p>\n<p>\n        <strong>Investor Contact\u00a0<\/strong><br \/>\n        <br \/>Matt Scalo\u00a0<br \/>(801) 584-3532\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IkQJsHZMsvEi61yFAmgKmkdp1mDbae_VKjFzG5oyY70A05P1BB1aZgoc5ocA3hMgmevDTfSS_NMb_-qOKO0Ukw==\" rel=\"nofollow\" target=\"_blank\"><u>IR@myriad.com<\/u><\/a>\u00a0<\/p>\n<p>\n        <strong>Media Contact\u00a0<\/strong><br \/>\n        <br \/>Kate Schraml<br \/>(224) 875-4493<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=SlgiBY0KTT40sLfauJOFujfZVRrkGmjzcN_vx_wYA2kDEbWuwyKHEsXGwsIZFpvaG0mzfNsMYdNrXg8L38IaRQ==\" rel=\"nofollow\" target=\"_blank\">PR@myriad.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MzI3NSM3MjU3MDk1IzIwMDc4ODc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjNlNjhlNDctNWZlZC00ZWNmLWEzY2ItOTliMGViN2QxMWM4LTEwMTk0NjAtMjAyNS0xMS0xMS1lbg==\/tiny\/Myriad-Genetics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SALT LAKE CITY, Nov. 11, 2025 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences. The 7th Annual Wolfe Research Healthcare Conference with a fireside chat on Tuesday, Nov. 18, 2025, at 1:20 pm ET. The 37th Annual Piper Sandler Healthcare Conference with a fireside chat on Tuesday, Dec. 2, 2025, at 12:00 pm ET. The presentations will be available through live audio webcast links in the investor information section of Myriad\u2019s website at\u00a0investor.myriad.com.\u00a0 About Myriad Genetics Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-908475","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SALT LAKE CITY, Nov. 11, 2025 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences. The 7th Annual Wolfe Research Healthcare Conference with a fireside chat on Tuesday, Nov. 18, 2025, at 1:20 pm ET. The 37th Annual Piper Sandler Healthcare Conference with a fireside chat on Tuesday, Dec. 2, 2025, at 12:00 pm ET. The presentations will be available through live audio webcast links in the investor information section of Myriad\u2019s website at\u00a0investor.myriad.com.\u00a0 About Myriad Genetics Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and &hellip; Continue reading &quot;Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-11T14:53:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MzI3NSM3MjU3MDk1IzIwMDc4ODc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences\",\"datePublished\":\"2025-11-11T14:53:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/\"},\"wordCount\":181,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3MzI3NSM3MjU3MDk1IzIwMDc4ODc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/\",\"name\":\"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3MzI3NSM3MjU3MDk1IzIwMDc4ODc=\",\"datePublished\":\"2025-11-11T14:53:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3MzI3NSM3MjU3MDk1IzIwMDc4ODc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU3MzI3NSM3MjU3MDk1IzIwMDc4ODc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk","og_description":"SALT LAKE CITY, Nov. 11, 2025 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences. The 7th Annual Wolfe Research Healthcare Conference with a fireside chat on Tuesday, Nov. 18, 2025, at 1:20 pm ET. The 37th Annual Piper Sandler Healthcare Conference with a fireside chat on Tuesday, Dec. 2, 2025, at 12:00 pm ET. The presentations will be available through live audio webcast links in the investor information section of Myriad\u2019s website at\u00a0investor.myriad.com.\u00a0 About Myriad Genetics Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and &hellip; Continue reading \"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-11-11T14:53:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MzI3NSM3MjU3MDk1IzIwMDc4ODc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences","datePublished":"2025-11-11T14:53:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/"},"wordCount":181,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MzI3NSM3MjU3MDk1IzIwMDc4ODc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/","name":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MzI3NSM3MjU3MDk1IzIwMDc4ODc=","datePublished":"2025-11-11T14:53:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MzI3NSM3MjU3MDk1IzIwMDc4ODc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU3MzI3NSM3MjU3MDk1IzIwMDc4ODc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/908475","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=908475"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/908475\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=908475"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=908475"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=908475"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}